SNAC & C10 Explained: How Permeation Enhancers Make Oral Semaglutide Possible?

Permeation enhancers are one of the key technologies helping researchers overcome the challenges of oral GLP-1 drug delivery. But how exactly do ingredients such as SNAC and C10 (salcaprozate) help a peptide like semaglutide get absorbed through the gastrointestinal tract? In this video, we take a closer look at permeation enhancers in oral GLP-1 formulations, with a focus on SNAC (salcaprozate sodium/C10) and their role in supporting the oral delivery of semaglutide. Peptide drugs such as semaglutide are challenging to administer orally because they can face enzymatic degradation, poor membrane permeability, and limited absorption in the gastrointestinal tract. Permeation-enhancing technologies are designed to address some of these barriers and improve the conditions for peptide absorption. In this video, you’ll learn: • What permeation enhancers are and why they are used in oral peptide drug delivery • How SNAC (salcaprozate sodium) works in oral semaglutide formulations • What C10/salcaprozate contributes to oral GLP-1 delivery • Why semaglutide presents unique challenges for oral administration • How the gastrointestinal environment affects peptide absorption • How permeation enhancers can influence drug exposure and absorption • Why oral peptide formulations require specialized formulation strategies • The formulation and manufacturing considerations associated with permeation enhancers • Why improving oral bioavailability can involve dose and formulation trade-offs • Key considerations when developing scalable oral GLP-1 drug delivery systems The video also looks at the broader pharmaceutical development question: what do permeation enhancers actually cost you? The cost is not limited to the excipient itself. Formulation developers may need to consider higher dose requirements, excipient levels, manufacturing complexity, stability, compatibility, analytical characterization, process optimization, and overall product development strategy. Understanding SNAC, salcaprozate, and other permeation-enhancing technologies is increasingly important as pharmaceutical companies explore oral GLP-1 drugs, oral semaglutide, peptide therapeutics, and next-generation oral drug delivery platforms. Whether you work in pharmaceutical formulation development, drug delivery, analytical testing, CDMO/CRO services, or are simply interested in the science behind oral GLP-1 therapies, this video provides a practical technical overview of how permeation enhancers work and the trade-offs developers need to consider. Watch the full video to understand how SNAC and C10 help address the challenges of oral semaglutide delivery and why improving peptide absorption can come with important formulation and development considerations. For more insights on pharmaceutical development, analytical characterization, peptide therapeutics, formulation development, and advanced drug delivery technologies, subscribe to our channel and follow our latest technical content. #OralGLP1 #Semaglutide #SNAC #Salcaprozate #PermeationEnhancers #GLP1 #OralSemaglutide #OralPeptideDelivery #PeptideDrugDelivery #DrugDelivery #PharmaceuticalDevelopment #PharmaceuticalFormulation #PeptideTherapeutics #GLP1Drugs #DrugDevelopment